Seres Therapeutics MCRB reported its Q4 earnings results on Tuesday, March 1, 2022 at 07:00 AM.
Here's what investors need to know about the announcement.
Earnings
Seres Therapeutics missed estimated earnings by 25.0%, reporting an EPS of $-0.55 versus an estimate of $-0.44.
Revenue was up $10.34 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $1.18 which was followed by a 8.34% drop in the share price the next day.
Here's a look at Seres Therapeutics's past performance:
Quarter | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 |
---|---|---|---|---|
EPS Estimate | -0.46 | -0.37 | -0.31 | -0.28 |
EPS Actual | 0.72 | -0.53 | -0.39 | -0.19 |
Revenue Estimate | 7.32M | 5.34M | 6.45M | 6.93M |
Revenue Actual | 126.72M | 5.26M | 5.72M | 17.56M |
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.